Health Products

PMS-Irbesartan/HCTZ Product Recall (2021-05-25)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I

Summary

Product

PMS-Irbesartan/HCTZ 300 mg/12.5 mg Tablet

Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberBrand nameCompaniesDIN, NPN, DIN-HIMDosage formStrength
624235B. PMS-Irbesartan/HCTZ 300 mg/25 mg Tablet
Recalling Firm
Pharmascience Inc.
100, 6111 Royalmount Avenue
Montreal
H4P 2T4
Quebec
CANADA
Marketing Authorization Holder
Pharmascience Inc.
100, 6111 Royalmount Avenue
Montreal
H4P 2T4
Quebec
CANADA
DIN 02328534TabletIrbesartan 300 mg
621822, 621823, 625902, 625318, 629920, 631052, 632583PMS-Irbesartan/HCTZ 300 mg/12.5 mg Tablet
Recalling Firm
Pharmascience Inc.
100, 6111 Royalmount Avenue
Montreal
H4P 2T4
Quebec
CANADA
Marketing Authorization Holder
Pharmascience Inc.
100, 6111 Royalmount Avenue
Montreal
H4P 2T4
Quebec
CANADA
DIN 02328526TabletIrbesartan 300 mg

Introduction

  1. PMS-Irbesartan/HCTZ 300 mg/12.5 mg Tablet
  2. PMS-Irbesartan/HCTZ 300 mg/25 mg Tablet

Reason

Presence of impurity 5-(4-(azidomethyl)-[1,1-biphenyl]-2-yl)-1H-tetrazole above the acceptable concentration limit in affected lots.

Depth of distribution

Retailers

For more information

Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime